Elix Provides AI Drug Discovery Platform to KYORIN Pharmaceutical

Aug 21, 2025
Elix, Inc. has announced that KYORIN Pharmaceutical Co., Ltd. has adopted its AI-powered drug discovery platform, Elix Discovery™, to enhance drug research and development.

Elix, Inc. has announced that KYORIN Pharmaceutical Co., Ltd. has adopted its AI-powered drug discovery platform, Elix Discovery™. This platform is designed to streamline the drug discovery process by utilizing AI technologies for molecular design and compound profiling.

Elix Discovery™ features an intuitive graphical user interface that allows users to build predictive models for optimal compound profiling. It supports both ligand-based and structure-based drug design, incorporating tools like docking simulations to enhance the drug discovery process.

The collaboration aims to accelerate KYORIN's research and improve its quality by integrating AI-driven drug discovery with KYORIN's existing capabilities. This partnership reflects a growing trend in the pharmaceutical industry to leverage AI technologies to address challenges such as long development timelines and high R&D costs.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.